These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 27359185)

  • 1. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.
    Ruoff C; Rye D
    Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
    Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
    Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1.
    Pizza F; Barateau L; Jaussent I; Vandi S; Antelmi E; Mignot E; Dauvilliers Y; Plazzi G;
    Neurology; 2019 Sep; 93(11):e1034-e1044. PubMed ID: 31405906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
    Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
    Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcolepsies, update in 2023.
    Barateau L; Pizza F; Chenini S; Peter-Derex L; Dauvilliers Y
    Rev Neurol (Paris); 2023 Oct; 179(7):727-740. PubMed ID: 37634997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid eye movement sleep duration during the multiple sleep latency test to diagnose hypocretin-deficient narcolepsy.
    Lopez R; Barateau L; Laura Rassu A; Evangelista E; Chenini S; Scholz S; Jaussent I; Dauvilliers Y
    Sleep; 2023 Jan; 46(1):. PubMed ID: 36222741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daytime continuous polysomnography predicts MSLT results in hypersomnias of central origin.
    Pizza F; Moghadam KK; Vandi S; Detto S; Poli F; Mignot E; Ferri R; Plazzi G
    J Sleep Res; 2013 Feb; 22(1):32-40. PubMed ID: 22716477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
    Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
    Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?
    Baumann C; Ferini-Strambi L; Waldvogel D; Werth E; Bassetti CL
    J Neurol; 2005 Feb; 252(2):139-45. PubMed ID: 15729517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.
    Andlauer O; Moore H; Jouhier L; Drake C; Peppard PE; Han F; Hong SC; Poli F; Plazzi G; O'Hara R; Haffen E; Roth T; Young T; Mignot E
    JAMA Neurol; 2013 Jul; 70(7):891-902. PubMed ID: 23649748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underutilization of the MSLT in sleepy patients with a short onset REM period (SOREMP) in the sleep clinic.
    Cairns A; Bogan R
    Sleep Med; 2017 Apr; 32():150-156. PubMed ID: 28366327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy.
    Gabryelska A; Szmyd B; Maschauer EL; Roguski A; Canham R; Morrison I; Białasiewicz P; Riha RL
    Sleep Med; 2020 Jul; 71():48-51. PubMed ID: 32492554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Does One Sleep-Onset REM Period—During Either Nocturnal Polysomnography or Multiple Sleep Latency Test—Mean in Differential Diagnosis of Central Hypersomnias?
    Bozluolcay M; Nalbantoglu M; Benbir Senel G; Karadeniz D
    J Clin Neurophysiol; 2015 Aug; 32(4):364-8. PubMed ID: 26241245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Clinical Correlates of a Short Onset REM Period (SOREMP) during Routine PSG.
    Cairns A; Bogan R
    Sleep; 2015 Oct; 38(10):1575-81. PubMed ID: 26039966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
    Dauvilliers Y; Lopez R
    Rev Prat; 2016 Jun; 66(6):671-6. PubMed ID: 27538328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.